CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Webinar actually not bad for a webinar. Lachlan coming on in...

  1. 729 Posts.
    lightbulb Created with Sketch. 205
    Webinar actually not bad for a webinar. Lachlan coming on in leaps and bounds! Demonstrates good platform in USA, on track for progress on a number of fronts before end of 2021 IMO. Sentiment a little better after today's lift. Hope it continues. GLTA
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.